WHO Reports Rising Bundibugyo Virus Cases in Congo and Uganda as U.S. Worker Is Evacuated to Germany
The World Health Organization reported on July 23, 2026, that confirmed cases and deaths from disease caused by Bundibugyo virus had increased substantially in the Democratic Republic of the Congo since its previous update on July 3. The outbreak also involves Uganda, making cross-border surveillance and response central to containing the epidemic.
The latest WHO report included another international health-worker development: a second U.S. citizen working as a humanitarian worker tested positive in the Democratic Republic of the Congo during July. The patient was medically evacuated to a university hospital in Frankfurt, Germany.
The available report does not provide the updated total number of confirmed cases or deaths in the source material reviewed for this article. The increase reported by WHO is therefore described as substantial without adding an unsupported numerical total.
An outbreak spanning two countries
WHO’s Director-General declared the epidemic in the Democratic Republic of the Congo and Uganda a public-health emergency of international concern on May 17, 2026. The designation is used for health events that carry potential international consequences and require a coordinated response across borders.
WHO said the determination did not meet the organization’s definition of a pandemic emergency. That distinction matters: the current designation signals serious international-health implications, but it does not mean WHO has classified the outbreak as a pandemic emergency.
The outbreak concerns Bundibugyo virus disease. It should not be treated as the same disease as Ebola virus disease caused by EBOV, even though the illnesses are related within the broader group of viral hemorrhagic fevers and the outbreak is commonly discussed in Ebola-response terms.
Health-worker exposure remains a concern
In its July 23 report, WHO identified persistent occupational exposure risks and inadequate infection-prevention and control practices as continuing concerns. Those risks are especially important in an outbreak involving health and humanitarian workers, who may come into contact with infected patients or contaminated materials while providing care and support.
The evacuation of the second infected U.S. humanitarian worker to Germany shows how the outbreak is also requiring international clinical and logistical coordination. The source material does not say where the patient acquired the infection beyond reporting that the worker tested positive in the Democratic Republic of the Congo. It also does not indicate that the patient acquired the infection in Germany.
For people outside the affected areas, the cross-border nature of the response is the practical issue to watch. The WHO report points to the need for surveillance, clinical response, infection-control measures and coordination between the Democratic Republic of the Congo, Uganda and international partners.
Vaccine evidence is limited
WHO issued emergency guidance on May 28 concerning the licensed Ebola vaccine Ervebo during Bundibugyo virus disease outbreaks. The agency said the available evidence for cross-protection against Bundibugyo virus was very limited and insufficient to reliably estimate vaccine effectiveness.
As a result, WHO recommended that Ervebo not be used programmatically for Bundibugyo outbreaks outside controlled research settings. That is not a finding that Ervebo is ineffective. It is a statement that, based on the evidence available on May 28, researchers could not reliably determine how well the vaccine protects against this virus.
The guidance instead emphasized surveillance, contact tracing, clinical management, infection prevention and control, and engagement with affected communities. WHO noted that the vaccine evidence may develop as research continues, so the May 28 guidance should be understood as based on the information available at that time.
What happens next
WHO’s latest report establishes a continuing need for cross-border monitoring and response but does not announce a new deadline or a separate final decision beyond the existing public-health emergency designation and vaccine guidance.
The immediate priorities identified in the approved WHO material are to strengthen surveillance, trace contacts, improve infection-prevention practices, support clinical care and work with communities. The July 23 update also keeps the focus on occupational exposure as the outbreak develops in the Democratic Republic of the Congo and Uganda.
Sources
- Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda, World Health Organization
- IHR Emergency Committee regarding the epidemic of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo and Uganda, World Health Organization
- WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks, World Health Organization
Discover more from Interactive News
Subscribe to get the latest posts sent to your email.
